IVD Market Report 2023 (Global Edition)

Global IVD Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing IVD Industry growth. IVD market has been segmented with the help of its Type, Application End-User , and others. IVD market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.

Report scope is customizable as we have a huge database of IVD industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.

Type analysis of In Vitro Diagnostics market.

Reagents

The Reagents segment Revenue will be USD 46,965.41 Million by 2028.

In vitro, diagnostic reagents are utilized in patient diagnosis, monitoring, and therapy operations. It is an important part of clinical chemistry and specialty chemical testing labs. In-vitro diagnostic reagents are classified into three types: chemical, biochemical, and immune-chemical. Chemical reagents are the most basic of the three, usually consisting of just one or two reagents. The working reagent is made of dyes, buffers, surfactants, and basic compounds (s). Biochemical reagents are more complicated and usually require more components to deal with. A biochemical reagent is used to determine glucose, a routinely performed diagnostic test in the clinical laboratory. Immunochemical reagents are made up of two or more reagents and contain a variety of processes and functioning components, such as buffers, conjugates, wash solutions, detection reagents, and serological markers, such as antibodies and antigens.

Instruments

There are several types of in vitro diagnostic instruments that offer features tissue diagnostics, hematological, immunodiagnostics, and molecular diagnostics. When utilized in IVD mode, the IVD Instrument is meant to be used as an IVD accessory. Several in vitro diagnostic (IVD) equipment have been developed for use in clinical laboratories. IVD equipment provides accurate, dependable screening and diagnostic testing with simple processes and integrated software

Services

In-vitro diagnostic services are provided by several firms. Many contract research firms cater to IVD producers' specific product development requirements. A variety of IVD services are specially designed to suit the high demands of the point-of-care diagnostic and life science industries. It may also make it easier to bring IVD devices to market more quickly. These services include assay development, production, and a variety of additional options

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of IVD Industry. Request a Free Sample PDF!

In Vitro Diagnostics market, by application

Infectious Diseases

The Infectious Diseases application segment Revenue in In Vitro Diagnostics will be USD 24,135.34 Million by 2028.

Infectious illnesses are produced when a microorganism (bacteria, virus, parasite, fungus, etc.) assaults the body. They can be passed from one person to another either directly or indirectly. In the event of infectious illnesses, in vitro diagnostic tests are used to detect and identify the infectious agent, as well as to locate the source of the infection and to help clinicians choose the best therapy for the patient. Such examinations are also necessary for preventing epidemics. There are three types of IVD testing for infectious diseases: traditional microbiology, immunoassaysand molecular diagnostics. Infectious infections have become more common in recent years. As a result, the use of IVD for infectious disorders is increasing.

Cancer

Cancer is the world's second-largest cause of death. Early cancer identification and access to good anti-cancer treatment can lead to increased survival rates and a higher quality of life. In-vitro diagnostics allow for early detection of cancer, allowing for more effective and timely treatment. Several persons diagnosed with cancer might look forward to a healthier future if they have access to IVDs. IVDs can also be used to identify whether a person is at risk of getting a certain form of cancer. Furthermore, improvements in IVDs not only promise improved results for cancer patients but also lower treatment costs, resulting in significant savings for health systems.

Cardiac Diseases

The first stage in a patient's recovery is to diagnose CVD. In-vitro diagnostics are employed at all phases of heart disease treatment. Many people are now living healthy lives years after being diagnosed with some of the world's most deadly diseases, such as heart disease. IVDs give data to assist in the delivery of successful therapy. The In-Vitro Diagnostics market's recent strong expansion offers a new generation of technology improvements, including improved alternatives for quick Point-of-Care testing for cardiac events

Immune System Disorders

In Vitro Diagnostics operations include the development of in vitro diagnostic instruments as well as the production of reagents and kits for use in the diagnosis and management of autoimmune illnesses. These IVD systems and reagents are used to detect viral infections, diagnose immune system illnesses, and assess human hormone responses in vitro. It employs a wide range of ready-to-use ELISA reagent kits to screen and detect viruses and other infectious agents and pathogens in blood, serum, plasma, and other bodily fluids.

Nephrological Diseases

IVD immunoassays are commonly used to determine kidney disease indicators in human biological samples such as serum, urine, and tissues quantitatively or qualitatively. ELISA (enzyme-linked immunosorbent assay), LFIA (lateral flow immunoassay), CLIA (chemiluminescent immunoassay), PETIA (particle-enhanced turbidimetric immunoassay), immunohistochemistry (IHC), and other immunoassay formats are often employed for kidney disease indicators. Different labels (such as fluorescent microspheres, biotin, HRP, colloidal gold, and latex) are coupled to biomarker-specific antibodies in these tests to generate signals. The use of these immunoassays provides reliable, quick, and cost-effective detection of kidney damage or illnesses due to the specificity and sensitivity of antibodies.

Gastrointestinal Diseases

Infectious disorders of the gastrointestinal tract are widespread across the world and are a leading source of morbidity and death, especially among newborns in underdeveloped countries. As a result, numerous businesses focus on offering IVD reagents, devices, or services for gastrointestinal illness detection. The use of an in vitro diagnostic test can assist in the qualitative identification and distinction of prevalent bacterial infections linked to gastrointestinal sickness

The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the IVD market report 2023 Edition by contacting our team.

IVD End-User Segment Analysis

Hospitals

The Hospitals segment Revenue in In Vitro Diagnostics will be USD 41,561.14 Million by 2028.

Due to its high demand, accuracy, and utility, in-vitro diagnostic solutions defined as medical devices and reagents used to examine specimens derived from the human body, such as blood, tissues, and other body fluids, to detect diseases, conditions, and infections have piqued the curiosity of the healthcare ecosystem. IVD tests can be performed in a hospital-based laboratory which is used for test sample preparation. Since the outbreak of the pandemic, many health institutions, in particular, hospitals, have had to focus their efforts on dealing with COVID-19.

Laboratories

There is a broad range of in-vitro diagnostics (IVDs), from self-tests for pregnancy and blood glucose tests for diabetics, to sophisticated diagnoses performed in clinical laboratories. The tests themselves can be performed on a variety of instruments ranging from small, handheld tests to complex laboratory instruments.

Clinics

The IVD point of care testing is widely used in clinics. These are carried out in coagulation clinics, dental clinics, diabetic clinics, polyclinics, sexual health clinics/GUM clinics, and many other clinics

Others

Several other users such as patient self-testing, academic & research institutes use in vitro diagnostic tests. Similarly, numerous home care facilities use In Vitro Diagnostics. IVD processes can range from simple at-home tests that are used to diagnose the presence of infections and disease, as well as monitoring at-home care.

• Hospitals
• Laboratories
• Clinics
• Others

IVD Market Regional Analysis

Region and country analysis section of IVD Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of IVD market.

Region-wise, the market is analyzed across: (In case you wish to acquire a specific region or any country data then please contact us)

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.

Company Profile:

bioMérieux SA

bioMérieux is specialized in offering in vitro diagnostics and molecular diagnostic solution in healthcare industries. The company offers several immunoassays, test, instrument for detection and diagnosis for infectious diseases, cancer, cardiac related conditon and other. The company offers system, reagents, software and services. The products offered in the portfolio are immunoassays, lab consultancy, microbiology, molecular diagnostics, and lab automation. Further, the company is also engaged in offering system services, laboratory and other services.

DiaSorin S.p.A

Dia Sorin S.p. A is specialized in offering laboratory diagnostic procedures under immunodiagnostic, molecular diagnostic segments. DiaSorin Molecular and Luminex Corporation is part of DiaSorin Group.The company delivers assays in the several areas such as infectious disease, oncology, stool diagnostic, autoimmunity, endocrinology, hypertension, and other. The company is engaged in development of CLIA, ELISA systems.

RECENT NEWS

July 2021

DiaSorin S.p.A has acquired Luminex Corporation

The company is engaged in acquisition with Luminex Corporation. This acquisition expanded the Luminex multiplexing technology and strengthen its presence in the U.S.

Top Companies Market Share in IVD Industry: (In no particular order of Rank)

• Roche Diagnostics
• Danaher Corporation
• Abbott Laboratories
• Siemens
• Sysmex
• Thermo Fisher Scientific
• Becton Dickinson and Company
• Biomrieux Sa
• Bio Rad Laboratories
• Johnson Johnson
• Agilent Technologies
• Qiagen
• Diasorin
• Ortho Clinical Diagnostics
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables..